Keywords: داروهای ضد ویروسی مستقیم; Competing risk; Direct-acting antivirals; Hepatitis C; Hepatocellular carcinoma; Markov model; Survival benefit; Sustained virological response;
مقالات ISI داروهای ضد ویروسی مستقیم (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: داروهای ضد ویروسی مستقیم; Direct-acting antivirals; Daclatasvir; Ledipasvir; Native fluorescence; Real human plasma; Pharmaceutical formulations;
Keywords: داروهای ضد ویروسی مستقیم; Broad-spectrum antivirals; Non-nucleoside inhibitors; Direct-acting antivirals; Norovirus; RNA-dependent RNA polymerase; Caliciviridae; BS-AV; broad-spectrum antivirals; CI; confidence intervals; FCV; feline calicivirus; IC50; half maximal inhibitory conc
Keywords: داروهای ضد ویروسی مستقیم; Direct-acting antivirals; Sofosbuvir; IFN-free regimens; Cryoglobulinemia; Lymphoma; HCV; Chronic kidney disease; Lichen planus;
Keywords: داروهای ضد ویروسی مستقیم; Hepatitis C; Direct-acting antivirals; Waiting list; Liver transplantation; Delisting;
Keywords: داروهای ضد ویروسی مستقیم; ANRS; (France REcherche Nord & sud Sida-vih Hépatites); HCV; hepatitis C virus; RNA; ribonucleic Acid; DAA; direct-acting antivirals; HCC; hepatocellular carcinoma; SVR; sustained virological response; RR; relative risk; INF; interferon; US; ultra-sound;
Keywords: داروهای ضد ویروسی مستقیم; HCV, hepatitis C virus; G3, genotype 3; SVR, sustained virological response; NS5A, non-structural 5A; PI, protease inhibitorHepatitis C virus; Direct-acting antivirals; Resistance-associated variants; Genotype 3; Cirrhosis; Chronic kidney disease (CKD); S
Keywords: داروهای ضد ویروسی مستقیم; Hepatitis C; Genotype 1; Direct-acting antivirals; Second generation; Resistance-associated variants;
Keywords: داروهای ضد ویروسی مستقیم; Hepatitis C; Direct-acting antivirals; Interferon; Treatment;
Keywords: داروهای ضد ویروسی مستقیم; Direct-acting antivirals; Hepatitis C; Cirrhosis; Sofosbuvir; Ledipasvir; Paritaprevir; Ombitasvir; Simeprevir;
Keywords: داروهای ضد ویروسی مستقیم; Hepatitis C virus; Liver transplant; Direct-acting antivirals; Recurrent hepatitis C virus; Sofosbuvir; Simeprevir; Ledipasvir; Cholestatic hepatitis;
Keywords: داروهای ضد ویروسی مستقیم; HCV; hepatitis C; LT; liver transplantation; DDI; drug-drug interactions; DAAs; direct-acting antivirals; PegINF; peginterferon; RBV; ribavirin; MELD; model of end-stage liver disease; PI; protease inhibitor; PR; peginterferon plus ribavirin; SAEs; seriou
Keywords: داروهای ضد ویروسی مستقیم; direct-acting antivirals; HCV; HIV; managed care organizations; sustained virologic response; underserved population
Access to hepatitis C virus treatment: Lessons from implementation of strategies for increasing access to antiretroviral treatment
Keywords: داروهای ضد ویروسی مستقیم; Acces to medicines; Hepatitis C virus; HIV; Antiretrovirals; Direct-acting antivirals;
Interferon- and ribavirin-free therapy with new direct acting antivirals (DAA) for chronic hepatitis C improves vascular endothelial function
Keywords: داروهای ضد ویروسی مستقیم; HCV; Extrahepatic manifestation; Direct-acting antivirals; DAA; Endothelial function; Vascular inflammation;
Increasing Prevalence of Hepatitis C among Hospitalized Children Is Associated with an Increase in Substance Abuse
Keywords: داروهای ضد ویروسی مستقیم; Hepatitis C; pediatrics; prevalence; inpatient; substance abuse; DAAs; Direct-acting antivirals; HCV; Hepatitis C virus; KID; Kids' Inpatient Database;
Anti-E1E2 antibodies status prior therapy favors direct-acting antiviral treatment efficacy
Keywords: داروهای ضد ویروسی مستقیم; Hepatitis C; Relapse; Direct-acting antivirals; Neutralizing antibodies; Sustained virological response; E1E2 envelope; HCV; hepatitis C virus; DAA; direct-acting antiviral; SVR; sustained virological response; RBV; ribavirin; PEG-IFN; pegylated-interfero
Prevalence of NS5A resistance associated variants in NS5A inhibitor treatment failures and an effective treatment for NS5A-P32 deleted hepatitis C virus in humanized mice
Keywords: داروهای ضد ویروسی مستقیم; HCV; Glecaprevir; Pibrentasvir; Sofosbuvir; NS5A inhibitor resistance associated variant; P32 deletion; Human hepatocyte chimeric mouse; ASV; asunaprevir; DAAs; Direct-acting antivirals; DCV; daclatasvir; GLE; glecaprevir; HCV; hepatitis C virus; LDV; led
Evaluation of TRIM5 and TRIM22 polymorphisms on treatment responses in Iranian patients with chronic hepatitis C virus infection
Keywords: داروهای ضد ویروسی مستقیم; HCV; hepatitis C virus; CHC; chronic HCV; HCC; hepatocellular cancer; SVR; sustained virologic response; TRIM; tripartite motif; pegIFN-α/RBV; pegylated interferon-α and ribavirin; DDAs; direct-acting antivirals; RVR; rapid virologic response; cEVR; com
State Medicaid Reimbursement for Medications for Chronic Hepatitis C Infection from 2012 through 2015
Keywords: داروهای ضد ویروسی مستقیم; DAAs; direct-acting antivirals; hepatitis C; Medicaid; sofosbuvir; specialty drugs;
Effectiveness and tolerability of direct-acting antivirals for chronic hepatitis C patients in a Southern state of Brazil
Keywords: داروهای ضد ویروسی مستقیم; Brazil; Direct-acting antivirals; Hepatitis C; Observational study;
Interleukin-7 augments CD8+ T cells function and promotes viral clearance in chronic hepatitis C virus infection
Keywords: داروهای ضد ویروسی مستقیم; ALT; alanine aminotransferase; CCK-8; Cell Counting Kit-8; DAAs; direct-acting antivirals; ELISA; enzyme-linked immunosorbent assay; HBV; hepatitis B virus; HCV; hepatitis C virus; HCVcc; HCV in cell culture; HIV; human immunodeficiency virus; IFN; interf
French Patients with Hepatitis C Treated with Direct-Acting Antiviral Combinations: The Effect on Patient-Reported Outcomes
Keywords: داروهای ضد ویروسی مستقیم; direct-acting antivirals; fatigue; health-related quality of life; health utility; work productivity;
Tratamiento del virus de la hepatitis C con antivirales de acción directa: Aspectos prácticos y situación actual
Keywords: داروهای ضد ویروسی مستقیم; Virus de la hepatitis C; Antivirales de acción directa; Hepatitis C virus; Direct-acting antivirals;
Long-Term Outcomes of Patients With HCV-Associated Cryoglobulinemic Vasculitis After Virologic Cure
Keywords: داروهای ضد ویروسی مستقیم; BVAS v3; Complication; Immunoglobulin; SVR; ACC; asymptomatic circulating cryoglobulin; BVAS.v3; Birmingham Vasculitis Activity Score version 3; CC; circulating cryoglobulin; CH50; total hemolytic complement fraction; CV; cryoglobulinemic vasculitis; DAA;
Model projections on the impact of HCV treatment in the prevention of HCV transmission among people who inject drugs in Europe
Keywords: داروهای ضد ویروسی مستقیم; Hepatitis C; PWID; Opioid substitution therapy; Direct-acting antivirals;
Executive summary of the 2018 KDIGO Hepatitis C in CKD Guideline: welcoming advances in evaluation and management
Keywords: داروهای ضد ویروسی مستقیم; antivirals; chronic kidney disease; cryoglobulinemia; dialysis; direct-acting antivirals; glomerular diseases; guideline; hemodialysis; hepatitis C virus; infection control; KDIGO; kidney transplantation; liver testing; nosocomial transmission; screening;
Hepatitis C Management Simplification From Test to Cure: A Framework for Primary Care Providers
Keywords: داروهای ضد ویروسی مستقیم; direct-acting antivirals; HCV; hepatitis C virus; nonspecialist; primary care; treatment;
Natural NS5A inhibitor resistance associated substitutions in hepatitis C virus genotype 1 infected patients from Italy
Keywords: داروهای ضد ویروسی مستقیم; Direct-acting antivirals; Drug resistance; Hepatitis C virus; NS5A; Pegylated interferon-α and ribavirin;
Sofosbuvir Based Regimen in Management of Hepatitis C for Patients With End Stage Renal Disease on Hemodialysis: A Single Center Experience from India
Keywords: داروهای ضد ویروسی مستقیم; CHC; chronic hepatitis C; DAA; direct-acting antivirals; ESRD; end stage renal disease; HCV; hepatitis C virus; SVR; sustained virologic response; hepatitis C; direct-antiviral agents; end-stage renal disease; liver cirrhosis;
Recombinant hepatitis C virus genotype 5a infectious cell culture systems expressing minimal JFH1 NS5B sequences permit polymerase inhibitor studies
Keywords: داروهای ضد ویروسی مستقیم; HCV; hepatitis C virus; DAA; direct-acting antivirals; ORF; open reading frame; UTR; untranslated region; E; envelope; nt; nucleotide; aa; amino acid; FFU/ml; focus forming units per milliliter; NI; nucleos(t)ide inhibitors; NNI; non-nucleoside inhibitors
Estimation of Hepatitis C Disease Burden and Budget Impact of Treatment Using Health Economic Modeling
Keywords: داروهای ضد ویروسی مستقیم; Markov modeling; Simulation; Health economics; Cost-effectiveness; Direct-acting antivirals; Hepatitis C elimination; Public health;
Hepatitis C virus deep sequencing for sub-genotype identification in mixed infections: A real-life experience
Keywords: داروهای ضد ویروسی مستقیم; HCV; Mixed infection; Deep sequencing; NGS; Direct-acting antivirals;
HCV phylogenetic signature and prevalence of pretreatment NS5A and NS5B NI-Resistance associated substitutions in HCV-Infected patients in Mainland China
Keywords: داروهای ضد ویروسی مستقیم; Direct-acting antivirals; Resistance associated substitutions; DAAs; direct-acting antiviral agents; NI; nucleoside/nucleotide inhibitor; PI; protease inhibitor; RAS; resistance-associated substitution; SVR; sustained virologic response; SVR12; sustained
Autoimmune Kidney Diseases Associated with Chronic Viral Infections
Keywords: داروهای ضد ویروسی مستقیم; Hepatitis C virus; Hepatitis B virus; Human immunodeficiency virus; Mixed cryoglobulinemia syndrome; Glomerulonephritis; Direct-acting antivirals; Interferon;
The efficacy of direct anti-HCV drugs improves early post-liver transplant survival and induces significant changes in waiting list composition
Keywords: داروهای ضد ویروسی مستقیم; HCV; Direct-acting antivirals; Liver transplantation; Waiting list;
HCV Genotype 6a Escape From and Resistance to Velpatasvir, Pibrentasvir, and Sofosbuvir in Robust Infectious Cell Culture Models
Keywords: داروهای ضد ویروسی مستقیم; DAA; Escape Variants; Nucleotide Analog; In Vitro System; aa; amino acid; DAA; direct-acting antivirals; EC50; half-maximal effective concentration; FFU/mL; focus forming units per milliliter; HCV; hepatitis C virus; NGS; next-generation sequencing; NI;
Planning and prioritizing direct-acting antivirals treatment for HCV patients in countries with limited resources: Lessons from the Egyptian experience
Keywords: داروهای ضد ویروسی مستقیم; HCV; Egypt; Direct-acting antivirals; Mass treatment; Prioritization;
Resistance analysis in patients with genotype 1-6 HCV infection treated with sofosbuvir/velpatasvir in the phase III studies
Keywords: داروهای ضد ویروسی مستقیم; Direct-acting antivirals; Sofosbuvir/velpatasvir; ASTRAL-1; ASTRAL-2; ASTRAL-3; ASTRAL-5; POLARIS-2; POLARIS-3;
Dengue virus NS2 and NS4: Minor proteins, mammoth roles
Keywords: داروهای ضد ویروسی مستقیم; Dengue virus; Non-structural proteins; Direct-acting antivirals; Drug discovery; Therapeutic targets; Small NS proteins;
The Mexican consensus on the treatment of hepatitis C
Keywords: داروهای ضد ویروسی مستقیم; Consensus; Direct-acting antiviral agents; Interferon-free regimens; Ribavirin; Consenso; Agentes antivirales de acción directa; RegÃmenes libres de interferón; Ribavirina; AASLD; American Association for the Study of Liver Diseases; AFP; alpha-fetopro
Eliminating hepatitis C within low-income countries - The need to cure genotypes 4, 5, 6
Keywords: داروهای ضد ویروسی مستقیم; HCV elimination; Direct-acting antivirals; Epidemiology; Chronic hepatitis C; Screening;
Effectiveness of Paritaprevir/Ritonavir/Ombitasvir/Dasabuvir in Hemodialysis Patients With Hepatitis C Virus Infection and Advanced Liver Fibrosis: Case Reports
Keywords: داروهای ضد ویروسی مستقیم; Hepatitis C virus (HCV); hemodialysis; cirrhosis; advanced liver fibrosis; sustained virological response; decreased kidney function; end-stage renal disease (ESRD); direct-acting antivirals; paritaprevir; ritonavir; ombitasvir; dasabuvir; ribavirin; HCV
Week 4 response predicts sustained virological response to all-oral direct-acting antiviral-based therapy in cirrhotic patients with hepatitis C virus genotype 3 infection
Keywords: داروهای ضد ویروسی مستقیم; Cirrhosis; Direct-acting antivirals; Hepatitis C virus genotype 3; Interferon-free regimens; Sustained virological response; Viral kinetics;
Respiratory adverse effects of Sofosbuvir-based regimens for treatment of chronic hepatitis C virus
Keywords: داروهای ضد ویروسی مستقیم; BHR; bronchial hyperresponsiveness; DAAs; direct-acting antivirals; FEF25-75%; forced expiratory flow in the middle part of FVC maneuver; FEV1; forced expiratory volume in 1st second; FVC; forced vital capacity; HCC; hepatocellular carcinoma; HCV; hepat
Addition of ribavirin to daclatasvir plus asunaprevir for chronic hepatitis C 1b patients with baseline NS5A resistance-associated variants improved response
Keywords: داروهای ضد ویروسی مستقیم; direct-acting antivirals; hepatitis C; resistance-associated variant;
Effectiveness of direct-acting antivirals in Hepatitis C virus infection in haemodialysis patients
Keywords: داروهای ضد ویروسی مستقیم; HCV infection; Direct-acting antivirals; Haemodialysis; Infección por el VHC; Antivirales de acción directa; Hemodiálisis;
Eficacia de los antivirales de acción directa en la infección por el virus de la hepatitis C en pacientes en hemodiálisis
Keywords: داروهای ضد ویروسی مستقیم; Infección por el VHC; Antivirales de acción directa; Hemodiálisis; HCV infection; Direct-acting antivirals; Haemodialysis;
Hepatitis C virus core antigen in the management of patients treated with new direct-acting antivirals
Keywords: داروهای ضد ویروسی مستقیم; Hepatitis C; Core antigen; Direct-acting antivirals; Viremia; Monitoring;
Efficacy and tolerability of interferon-free antiviral therapy in kidney transplant recipients with chronic hepatitis C
Keywords: داروهای ضد ویروسی مستقیم; Renal transplantation; Direct-acting antivirals; Hepatitis C; Liver transplant; Immunosuppressive therapy;